Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office

One year after the spread of the pandemic, we analyzed the assessment results of the quality documentation submitted to the Clinical Trials Office of the Italian Medicines Agency as part of the request for authorization of clinical trials with a COVID-19 indication. In this article, we report the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dri, Diego Alejandro, Praticò, Giulia, Gaucci, Elisa, Marianecci, Carlotta, Gramaglia, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709226/
https://www.ncbi.nlm.nih.gov/pubmed/34959722
http://dx.doi.org/10.3390/ph14121321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709226/
https://www.ncbi.nlm.nih.gov/pubmed/34959722
http://dx.doi.org/10.3390/ph14121321

Ejemplares similares